Persistent Pain and Its Impact on Quality of Life COVID-19 Patients That Required Critical Care

Summary

Participation Requirements

Description

The presence of persistent pain and impaired quality of life in COVID19 patients who have required intensive care can affect up to a total of 50% of patients. Main objective Estimate the level of persistent pain and health-related quality of life after admission one in intensive care unit in COVID-1...

The presence of persistent pain and impaired quality of life in COVID19 patients who have required intensive care can affect up to a total of 50% of patients. Main objective Estimate the level of persistent pain and health-related quality of life after admission one in intensive care unit in COVID-19 patients, a new disease that has been accompanied by great health, social and economic involvement from which we do not know the long-term consequences in this patient cohort. Secondary goals Assessing patient's characteristics before ICU admissión; the prevalence of painkillers use, including opioids, history of previous pain, and comorbidities. Find relationships between these characteristics and the development of chronic pain. Determine if some ICU treatments and patient's characteristics may contribute to persistent pain in COVID-19 survivors ( number of prone therapies, thromboembolic complications, and medication for sedate used) Determine the quality of life using the SF-12 test. Determine pain characteristics using the ID-PAIN test. Determine the scale of anxiety and depression using the HADs test.

Tracking Information